Background/Objectives: Juvenile myelomonocytic leukemia (JMML) is a rare and very aggressive pediatric myelodysplastic/myeloproliferative neoplasm with molecular heterogeneity and constitutive activation of the RAS signaling pathway. The aim of this study was to identify the mutational landscape, driver genes, mutation...
Harsh Goel, R. Majhi, J. Meena et al.· Medical Science· 0 citations
The review supports routine TPMT and NUDT15 genotyping and highlights the need for harmonised definitions, multi-ethnic studies, standardised data representation, and prospective validation of identified variants, which remains to be evaluated prospectively.
Santenna Chenchula, S. Srinivasamurthy, Vinnyfred Vincent et al.· Pharmaceuticals· 0 citations
This study provides a comprehensive characterization of epigenetic regulator gene alterations in JMML and highlights the importance of epigenetic dysregulation in disease pathogenesis.
Harsh Goel, R. Majhi, J. Meena et al.· Epigenomes· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.